Starting in 2025, the Inflation Reduction Act will limit Medicare drug plan members' spending on covered drugs at $2,000 per ...

In the past few years, the Centers for Medicare & Medicaid Services has significantly increased its utilization of discretionary denials of payment ...

As part of its Modernization Initiative, the Department of Health and Human Services’ Office of Inspector General (OIG) ...

With over 12 years in the pharmaceutical industry, Fayazoddin Mohamad excels in regulatory compliance and pharmacy management ...

What's changing? Starting in 2025, Medicare Part D out-of-pocket costs will be capped at $2,000 annually, eliminating the ...

The rising cost of prescription drugs under Medicare continues to pose significant challenges for seniors, a population that relies heavily ...

“We stand committed as an organization to ensuring compliance with all regulatory requirements and the company prides itself ...

More than 20% of SNF did not comply with Medicare guidelines that require the disclosure of related-party transactions.

PatientRightsAdvocate.org (PRA) has released its Seventh Semi-Annual Hospital Price Transparency Report, revealing a ...

Dr. Mehmet Oz, President-elect Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services (CMS), has a mandate from Trump to “take on the illness industrial complex” and to cut costs.

The Compliance-Focused Transparency Reporting Solution For 2025 The life sciences industry is remarkably dynamic as it introduces novel therapies to improve healthcare outcomes and yet it continues to ...